Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3858279 in Painful Diabetic Peripheral Neuropathy
CTR20233574Phase 2Terminated
- Sponsor
- Not applicable
- Start
- Nov 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GSK3858279 in diabetic polyneuropathy (DPN), sponsored by Not applicable. Started Nov 2023; status: terminated.
02
Drugs
GSK3858279
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20233574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233574.